(Q43102710)

English

Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy

scientific article published on 18 May 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

lopinavir/ritonavir

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philippe Flandre

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Jean-François Delfraissy

13

object named as

Jean-François Delfraissy

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Christine Rouzioux

14

object named as

Christine Rouzioux

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Anne-Marie Taburet

12

object named as

Anne-Marie Taburet

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Constance Delaugerre

1

object named as

Constance Delaugerre

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Philippe Ngo Van

10

object named as

Philippe Ngo Van

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Isabelle Cohen-Codar

9

object named as

Isabelle Cohen-Codar

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

François Raffi

5

object named as

François Raffi

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Marie-Laure Chaix

3

object named as

Marie Laure Chaix

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

4

object named as

Jade Ghosn

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

MONARK Study Group

15

object named as

MONARK Study Group

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

author name string

Pierre Dellamonica

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

H Jaeger

7

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

D Shürmann

8

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Michael Norton

11

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

18 May 2009

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

53

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

7

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

2934-2939

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

25 May 2018

A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

25 May 2018

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

25 May 2018

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

25 May 2018

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

15 August 2018

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704639

1 December 2018

Update of the drug resistance mutations in HIV-1: Spring 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/19451297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01643-08

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43102710&oldid=1980843539"